Aa Aa Aa

Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis.

Find out more.


  • March 25, 2014

    Sucampo Co-Founder and Chairman Emeritus, Dr. Ryuji Ueno, to Receive Visionary Award from the Foundation Fighting Blindness

  • March 14, 2014

    Sucampo and Takeda Announce Update on Liquid Formulation Program for AMITIZA® (lubiprostone)

  • March 12, 2014

    Sucampo Receives Notice that Second Indication for AMITIZA for Opioid-Induced Constipation Is Not Approved by Medicines and Healthcare Products Regulatory Agency in U.K.

  • March 5, 2014

    Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2014 ROTH Conference